JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Quadruple Screening [15-21+6 Weeks; hCGB + AFP + uE3 + Inhibin-A] BPD: 31-52 mm
Quadruple Screening [15-21+6 Weeks; hCGB + AFP + uE3 + Inhibin-A] BPD: 31-52 mm
Test code:
STS002
Quadruple Screening [15-21+6 Weeks; hCGB + AFP + uE3 + Inhibin-A] BPD: 31-52 mm
The Second-Trimester Screening is an non-invasive evaluation that combines a maternal blood screening test with an ultrasound evaluation of the fetus to identify risks for specific chromosomal abnormalities, including Trisomy-21, Trisomy-18 and Trisomy 13
| Test Code | STS002 |
|---|---|
| Test Summary | The Second-Trimester Screening is an non-invasive evaluation that combines a maternal blood screening test with an ultrasound evaluation of the fetus to identify risks for specific chromosomal abnormalities, including Trisomy-21, Trisomy-18 and Trisomy 13 |
| Turn Around Time | 2 days |
| Acceptable Sample Types | Serum |
| NY Approved | No |
| Accreditations | CAP , ISO 15189（NABL） |
*TAT starts after the sample and all required sample information is received at the processing laboratory.
**The CPT codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association, and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party.
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location.
**The CPT codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association, and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party.
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location.
Test code:
STS002
This test is not available in your region Japan, please select your nearest laboratory to request more information.
Revvity Sites Globally
Select your location.
Test information
Test description
The Second-Trimester Screening is an early optional non-invasive evaluation that combines a maternal blood screening test with an ultrasound evaluation of the fetus to identify risks for specific chromosomal abnormalities, including Down Syndrome Trisomy-21 and Trisomy-18.
Indications for testing
The maternal serum screening test is a blood test offered to pregnant women. It helps to inform them of the chance of their unborn child having Down syndrome, Edward syndrome or a Patau Syndrome.
Condition description
This Second Trimester Screening is performed between the 16th and 21st week of pregnancy.
Test methods and limitations
Time Resolved Fluoroimmunoassay (TRFIA)
Detailed sample requirements
Serum
| Collection Container(s) |
Serum tubes (red top) |
|---|---|
| Collection |
Collect blood by venipuncture, allow it to clot, and separate the serum by centrifugation as quickly as possible. |
| Sample Condition |
Serum samples can be stored for at least 30 days at +2 – +8 degrees Celsius |
| Shipping |
Ship overnight at +2 – +8 degrees Celsius ensuring receipt within 2 days of collection. |
How To Order
Step 1
Choose Your Test
Select the correct test for your patient, and download and fill out the Clinical Genomics test requisition form.
Step 2
Collect Sample
Obtain a sample for testing from the patient using one of the provided Revvity Omics test packs.
Step 3
Send Samples
Send samples and all required forms back to Revvity for processing using pre-paid shipping label.
How can we help you?
We are here to answer your questions.
